hercynine and Hyperglycemia

hercynine has been researched along with Hyperglycemia* in 2 studies

Other Studies

2 other study(ies) available for hercynine and Hyperglycemia

ArticleYear
Ergothioneine products derived by superoxide oxidation in endothelial cells exposed to high-glucose.
    Free radical biology & medicine, 2017, Volume: 108

    Ergothioneine (Egt), 2-mercapto-L-histidine betaine (ESH), is a dietary component acting as antioxidant and cytoprotectant. In vitro studies demonstrated that Egt, a powerful scavenger of hydroxyl radicals, superoxide anion, hypochlorous acid and peroxynitrite, protects vascular function against oxidative damages, thus preventing endothelial dysfunction. In order to delve the peculiar oxidative behavior of Egt, firstly identified in cell free-systems, experiments were designed to identify the Egt oxidation products when endothelial cells (EC) benefit of its protection against high-glucose (hGluc). HPLC-ESI-MS/MS analyses revealed a decrease in the intracellular GSH levels and an increase in the ophthalmic acid (OPH) levels during hGluc treatment. Interestingly, in the presence of Egt, the decrease of the GSH levels was lower than in cells treated with hGluc alone, and this effect was paralleled by lower OPH levels. Egt was also effective in reducing the cytotoxicity of H

    Topics: Animals; Antioxidants; Betaine; Cattle; Cell Death; Cell-Free System; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Ergothioneine; Glucose; Glutathione; Histidine; Hydrogen Peroxide; Hyperglycemia; Oligopeptides; Oxidation-Reduction; Oxidative Stress; Sulfonic Acids; Superoxides; Tandem Mass Spectrometry

2017
Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: Involvement of SIRT1 and SIRT6.
    Free radical biology & medicine, 2016, Volume: 96

    Ergothioneine (Egt), the betaine of 2-mercapto-L-histidine, is a dietary antioxidant protecting against many diseases, including cardiovascular disease (CVD), through a redox mechanism different from alkylthiols. Here, experiments were designed to evaluate the mechanisms underlying the beneficial effect of Egt against hyperglycaemia-induced senescence in endothelial cells. To this end, cells were incubated with increasing concentrations of Egt (0.01-1.00mM) for 12h followed by incubation for 48h with high-glucose (25mM). Cell evaluation indicated that viability was not affected by mM concentrations of Egt and that the high-glucose cytotoxicity was prevented with the highest efficacy at 0.5mM Egt. The cytoprotective effect of Egt was paralleled by reduced ROS production, cell senescence, and, interestingly, the formation of hercynine (EH), a betaine we recently found to be produced during the Egt oxidation pathway. Notably, the Egt beneficial effect was exerted through the upregulation of sirtuin 1 (SIRT1) and sirtuin 6 (SIRT6) expression and the downregulation of p66Shc and NF-κB. SIRT1 activity inhibition and SIRT6 gene silencing by small interfering RNA abolished the protective effect of Egt against the high-glucose-induced endothelial senescence. These data provide the first evidence of the Egt ability to interfere with endothelial senescence linked to hyperglycaemia through the regulation of SIRT1 and SIRT6 signaling, thus further strengthening the already assessed role of these two histone deacetylases in type 2 diabetes.

    Topics: Antioxidants; Betaine; Cellular Senescence; Diabetes Mellitus, Type 2; Endothelial Cells; Ergothioneine; Gene Expression Regulation; Glucose; Histidine; Humans; Hyperglycemia; Oxidative Stress; Sirtuin 1; Sirtuins; Src Homology 2 Domain-Containing, Transforming Protein 1

2016